ANN ARBOR ? The impact of Pfizer Inc.?s $1.3 billion acquisition of Esperion Therapeutics continues to be felt in the Michigan life sciences industry a year after the deal closed. The incredibly lucrative Esperion exit was by far the biggest for any Michigan technology company this far, providing the state with a poster child to
ANN ARBOR - Aastrom Biosciences has expanded the U.S. Phase I/II clinical trial of its adult stem cell-based Tissue Repair Cells in the treatment of severe long bone non-union fractures to include the Department of Orthopedic Surgery at William Beaumont Hospital, the third U.S. site engaged in the trial. The Principal Investigator for Beaumont, Dr.
ANN ARBOR - Genetics Squared has appointed Dr. Peter Lenehan as chief medical officer and Dr. David Fry chief science officer, former targeted oncology drug development team members at Pfizer and Parke-Davis/Warner-Lambert. "Genetics Squared is very excited to add these two exceptional individuals to its management team," said president and CEO John Freshley. "They have
MIDLAND ? One of the state?s largest technology companies, Dow Corning Life Sciences, will meet with the leaders of the next generation of biotechnology in Michigan next month at a conference that takes a look at the current state of Life Sciences and beyond. The conference is co hosted by Michigan State University, Midland Tomorrow,
LANSING ? Life Sciences start ups in Michigan will get $30 million from the Michigan Technology Tri-Corridor this fiscal year, but funding for Homeland Security technology and Advanced Automotive Manufacturing technology has yet to be determined. The news came as MichBio, the state Life Sciences trade association, released a statement Monday saying Gov. Jennifer Granholm
ANN ARBOR ? A study released Monday by MichBio, the state?s life sciences trade association, shows if the federal government approves a wholesale drug importation bill now before Congress, it could cost Michigan up to 133,000 jobs and $35 billion in personal income over the next decade. The study funded by Pfizer, the world?s largest
ANN ARBOR - Aastrom Biosciences has created a new position ? Vice President Global Research ? and appointed Indiana University professor Janet Hock to the post. Hock will be responsible for Aastrom's biological research efforts including the bone and tissue regeneration research programs and related clinical development activities. "In selecting Dr. Hock as Aastrom's first
LANSING ? As reported earlier, $26.5 million is available this fiscal year from the Michigan Technology Tri-Corridor to fund research, development and commercialization projects in life sciences. Unlike last year, money for auto technology and homeland security technology will not bleed cash from life sciences starts ups. But now the story reported by Mitechnews.Com is
MOUNT PLEASANT ? MultiGEN Diagnostic, a Canadian biotech company that specializes in new DNA-based technologies, will join Central Michigan University?s Nanotechnology Cluster in January. MultiGEN will be housed in CMU's Health Professions Building. T.V. Moorthy, Bio-ID Diagnostic Inc. president and chief executive officer, said CMU's research environment was a key factor in the decision. "There
ANN ARBOR ? Aastrom Biosciences, following a familiar pattern among life sciences start ups, posted another big loss in the first fiscal quarter of its year ? some $2.65 million. The good news is the loss is less than the same quarter a year ago, when the tissue damage repair company lost $2.8 million. But